BSE Live
Dec 03, 16:02Prev. Close
38.84
Open Price
38.84
Bid Price (Qty.)
38.36 (1)
Offer Price (Qty.)
38.91 (175)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.17 | 0.72 | 0.95 | 1.06 | 0.35 | |
| Net CashFlow From Operating Activities | 1.00 | 0.26 | 0.84 | -0.29 | 0.81 | |
| Net Cash Used In Investing Activities | -3.11 | -2.45 | -4.75 | -0.93 | -0.13 | |
| Net Cash Used From Financing Activities | 1.99 | 2.38 | 3.45 | 0.00 | 0.47 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.12 | 0.18 | -0.46 | -1.22 | 1.15 | |
| Cash And Cash Equivalents Begin of Year | 0.25 | 0.06 | 0.52 | 1.74 | 0.59 | |
| Cash And Cash Equivalents End Of Year | 0.13 | 0.25 | 0.06 | 0.52 | 1.74 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y